KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $3.02 $6.17 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $3.02 $7.25
52 weeks $1.20 $10.26

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
Oct 22, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 21, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 20, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 19, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 18, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 15, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 14, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 13, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 12, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 11, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 08, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 07, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 06, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 05, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 04, 2021 $8.54 $8.54 $8.54 $8.54 0
Oct 01, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 30, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 29, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 28, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 27, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 24, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 23, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 22, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 21, 2021 $8.54 $8.54 $8.54 $8.54 0
Sep 20, 2021 $8.54 $8.54 $8.54 $8.54 0
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT